Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Classical hematology 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Neutropenia 1Febrile Neutropenia 1Fatigue 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Tretinoin 2Gemcitabine 2venetoclax 1trametinib 1talazoparib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1isoquercitrin 1idelalisib 1ferric carboxymaltose 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1dehydroftorafur 1darolutamide 1dacomitinib 1dabrafenib 1copanlisib 1cobimetinib 1cabozantinib 1cabazitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Sodium Chloride × Classical hematology × Clear all
NCT00294203 2014-04-15

Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer

University of Florida

Phase 1 Completed
40 enrolled
Classical hematologyGastrointestinal

Anemia, Fatigue, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡